Trials / Conditions / Recurrent Cholangiocarcinoma
Recurrent Cholangiocarcinoma
4 registered clinical trials studyying Recurrent Cholangiocarcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangio NCT06178588 | University of Kansas Medical Center | Phase 2 |
| Active Not Recruiting | Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Muta NCT03212274 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder C NCT03257761 | University of Southern California | Phase 1 |
| Withdrawn | Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Ch NCT02856568 | Mayo Clinic | Phase 1 |